CEFTIBUTEN DOSING REGIMENS
Disclosed herein are dosing regimens of ceftibuten in combination with a β-lactamase inhibitor. The dosing regimens include ceftibuten at a dose higher than 400 mg per day (for example, 400 mg BID, 600 mg QD or BID, or 800 mg QD or BID).
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
21.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!